Hologic, Inc. (HOLX) Stock: A Look at the Analyst Recommendations

Hologic, Inc. (NASDAQ: HOLX) has a higher price-to-earnings ratio of 36.86x compared to its average ratio. HOLX has 36-month beta value of 1.02. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”

The public float for HOLX is 231.12M, and currently, short sellers hold a 2.01% ratio of that float. The average trading volume of HOLX on April 04, 2024 was 1.84M shares.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

HOLX) stock’s latest price update

Hologic, Inc. (NASDAQ: HOLX)’s stock price has increased by 1.91 compared to its previous closing price of 76.08. However, the company has seen a 1.79% increase in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-03 that Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HOLX’s Market Performance

Hologic, Inc. (HOLX) has experienced a 1.79% rise in stock performance for the past week, with a 3.93% rise in the past month, and a 7.00% rise in the past quarter. The volatility ratio for the week is 1.48%, and the volatility levels for the past 30 days are at 1.61% for HOLX. The simple moving average for the last 20 days is 2.03% for HOLX stock, with a simple moving average of 5.27% for the last 200 days.

Analysts’ Opinion of HOLX

Needham, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $95. The rating they have provided for HOLX stocks is “Buy” according to the report published on July 14th, 2023.

RBC Capital Mkts gave a rating of “Sector Perform” to HOLX, setting the target price at $75 in the report published on December 07th of the previous year.

HOLX Trading at 3.48% from the 50-Day Moving Average

After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.78% of loss for the given period.

Volatility was left at 1.61%, however, over the last 30 days, the volatility rate increased by 1.48%, as shares surge +5.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.71% upper at present.

During the last 5 trading sessions, HOLX rose by +1.79%, which changed the moving average for the period of 200-days by -4.33% in comparison to the 20-day moving average, which settled at $76.17. In addition, Hologic, Inc. saw 8.51% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HOLX starting from GARRETT SCOTT T, who sale 16,441 shares at the price of $75.50 back on Mar 14 ’24. After this action, GARRETT SCOTT T now owns 48,611 shares of Hologic, Inc., valued at $1,241,296 using the latest closing price.

CRAWFORD SALLY, the Director of Hologic, Inc., sale 9,039 shares at $76.40 during a trade that took place back on Mar 08 ’24, which means that CRAWFORD SALLY is holding 132,927 shares at $690,607 based on the most recent closing price.

Stock Fundamentals for HOLX

Current profitability levels for the company are sitting at:

  • 0.19 for the present operating margin
  • 0.62 for the gross margin

The net margin for Hologic, Inc. stands at 0.16. The total capital return value is set at 0.08. Equity return is now at value 10.57, with 5.80 for asset returns.

Based on Hologic, Inc. (HOLX), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.39. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 10.6.

Currently, EBITDA for the company is 1.2 billion with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of 5.83. The receivables turnover for the company is 4.82for trailing twelve months and the total asset turnover is 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.89.

Conclusion

To put it simply, Hologic, Inc. (HOLX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts